Even so, developing a vaccine promoting CD8+T cell memory against viral infections and cancers is a difficult task due to their heterogeneity, which arises due to their progressive loss of effector functions, overexpression of immune checkpoints/inhibitory receptors, dysregulated transcriptional and epigenetic programming mechanisms, and unknown signaling mechanisms responsible for their development [170]. This evidence concerns the gene CD8A and cancer.